24/7
Buzz
Startups
VC
AI
Innovation
Opinions
Events
Promising Startups 2024
BiblioTech
Boarding Pass
Corporate
Appointments
CTalk
Tech Gateways
2025 VC survey
@Finance
Ctech Testimonials
Shopping
Projects
About
Newsletter
Contact us
RSS
Facebook
Twitter
ACCESSIBILITY
by
Homepage
FSD Pharma
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
Innovation
OPINIONS
EVENTS
SHOPPING
ABOUT
Terms Of Use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
21:55
TikTok's US shutdown: a high-stakes game of geopolitical chess
14:18
Full list of Israeli startup M&As in 2025
14:15
Trump’s second term begins with crypto, controversy, and sweeping reforms
13:28
Facial recognition firm Oosto, formerly AnyVision, sold for $125M after raising $352M
More stories
Buzz
Most popular
Daily
Weekly
1
Facial recognition firm Oosto, formerly AnyVision, sold for $125M after raising $352M
2
"Wiz is the world's fastest-growing cyber company and together we can build the largest security company to come out of Israel"
3
Warburg Pincus Signs Deal to Acquire Israeli Credit Card Issuer for $680 Million
4
Survey finds 50% of high-tech startups in Israel may exhaust funds in six months
5
"Everyone will be a manager" - what the world of work will look like with AI agents
More news
FSD Pharma
3 stories about FSD Pharma
FSD Pharma’s Acquisition of Therapix Hits a Snag
12.12.18
|
Tzally Greenberg
In October, FSD agreed to buy Therapix for $48 million in stock, but a Tuesday filing by Therapix revealed that the companies have returned to the negotiating table
FSD Pharma Co-Chairman on Where the Cannabis Industry Is Headed
28.11.18
|
Tzally Greenberg
On a visit to Israel, the co-chairman of the company said he believes cannabis research is going to come from Israel and Australia. He expects China to become a significant player in the cannabis market
Canada's FSD Pharma to Acquire Israeli Therapix Biosciences for $48 Million in Stock
23.10.18
|
Lilach Baumer
Clinical-stage Therapix Biosciences develops cannabinoid-based drugs for the treatment of neurological conditions, pain management, and infectious diseases
Please ensure Javascript is enabled for purposes of
website accessibility